SCHEMBL26335585

SCHEMBL26335585

c1ccc(-c2c(-c3ccccc3)c3cc(N(c4cccc5ccccc45)c4cccc5oc6ccccc6c45)ccc3c3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ABCG2 Q9UNQ0 2/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ MAPK3 P27361 1/20 0.32
▸ AHR P35869 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ DUSP3 P51452 1/20 0.31
▸ GABRP O00591 1/20 0.30
▸ GABRD O14764 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ CA12 O43570 1/20 0.30
▸ TNKS O95271 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ ABCB1 P08183 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14134089 0.96 TDP1 (0.35) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL26335476 0.95 TDP1 (0.36) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL14133826 0.94 TDP1 (0.34) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL26339533 0.92 PLA2G2A (0.34) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL26337008 0.92 PLA2G2A (0.33) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL26335407 0.91 TDP1 (0.31) TDP1L3MBTL1CA1CA2
SCHEMBL26335569 0.91 TDP1 (0.36) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL14133095 0.90 CA1 (0.35) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL26336028 0.90 CYP1A1 (0.38) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL26335495 0.90 TDP1 (0.34) TDP1L3MBTL1ABCG2CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 TDP1 2135/4885L3MBTL1 452/4885ABCG2 4004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback